Monitoring ARIA in Anti-Amyloid Therapy in Alzheimer'sAdvancements in Alzheimer's treatment focus on early intervention via antiamyloid-beta monoclonal antibodies to target disease causes rather than just symptoms.
PharmAbcine Announces Safety Approval for 4mg Single-dose Cohort in Phase 1 Clinical Trial of PMC-403 for Neovascular Age-related Macular DegenerationPharmAbcine is advancing monoclonal antibody therapy, significantly targeting diseases with high efficacy and low side effects.
Did Tim Walz discriminate against white people over COVID-19 treatments? Claims of such distort his plan - PoynterAccess to monoclonal antibody treatments during the pandemic in Minnesota was prioritized based on various risk factors, including race, which, as an approach, has been misrepresented.